ApoGen increases 2016 Series A funding round to $11 million
Company draws $4 million in additional funding from Merck KGaA's venture capital arm and other investors.
Company draws $4 million in additional funding from Merck KGaA's venture capital arm and other investors.
WuXi PharmaTech, a Chinese R&D powerhouse, is launching its second fund. It wants to invest $250 million into healthcare and life sciences startups in the U.S. and China.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.